|
|
|
|
| Advertisement |
 |
|
|
| Advertisement |
Looking for physician respondents for your surveys?
Medscape Market Research doesn't rely on traditional methods. Let us help you find the exact physicians you need to quickly answer your market research questions.
 Learn about the Medscape difference today.
|
|
| Advertisement |
No Cancer Left Behind: Drug Combination with Device Aims to Improve Cancer Outcomes
The pace of cancer innovation is at an all-time high, including new surgical and therapeutic technologies.
In this Q&A, Lumicell CEO Kelly Londy discusses data on new drug-device technology presented this week at the 2017 San Antonio Breast Cancer Symposium. The new approach allows cancer surgeons to know how much tissue needs to be removed 'real-time' during the first surgery, reducing the need for re-excisions.
 Read more here
|
|
| Strategy |
 |
|
Taking Command of Strategy Execution |
Mark Bouch, Stephen Bungay, and David Roblin outline how the technique of "mission command", a military approach to setting direction and executing strategy in the pharmaceutical industry, has developed over the last ten years
… /Read more/ |
|
|
| Advertisement |
Free White Paper: Customer Experience in Pharma with UCB, Teva and Pfizer.
5 case studies from industry leaders on how they are exceeding customers expectations and creating "wow" moments.
 Learn more
|
|
|
|
|
ADVERTISEMENT
 
|
| Calendar |
|
|
/ December 12: Specialty Products Data Strategy Summit / |
|
Philadelphia, PA |
|
/ January 23–24: 13th Biosimilars Summit / |
|
Alexandria, VA |
|
/ January 24–25: Reimbursement and Contracting / |
|
Philadelphia, PA |
|
/ February 27–28, 2018: Speaker Programs 2018 / |
|
Philadelphia, PA |
|
/ March 25–28, 2018: 14th Annual Pharma Forum / |
|
Philadelphia, PA |
|
/ March 28–29, 2018: Expanded Access Programs / |
|
Washington, DC |
|
/ April 11–12, 2018: 8th Annual Global Transparency Reporting Congress
/ |
|
London, UK |
|
|
|
| Advertisement |
 |
|
|
| Advertisement |
New Video Series! COMMERCIAL INSIGHTS into DIGITAL TRENDS
In this video series, produced in partnership with Veeva Systems, Pharmaceutical Executive speaks with biopharma and industry experts about the future of life sciences commercial capabilities and the hottest trends affecting this important market segment. Filmed live at the 9th Annual Veeva Systems' Global Commercial and Medical Summit.
 Learn more
|
|
|
|
|
|
|
| Industry update |
| // Pertinax Pharma (Bristol, UK) appointed Nigel Brooksby, former ABPI president and UK Life Sciences Strategy Board chairman, as chairman of the company. // BioAtla (San Diego, CA) appointed James Allison, Ph.D., and Padmanee Sharma, M.D., Ph.D., as scientific advisors. // Vital Therapies (San Diego, CA) named Russell J. Cox as chief executive officer and member of its Board of Directors, effective January 3, 2018. // Sunesis Pharmaceuticals announced that Daniel Swisher has resigned from his position as president and CEO, effective December 31, 2017. The Sunesis Board of Directors has appointed Dayton Misfeldt as interim CEO, effective January 1, 2018. |
| Advertisement |
GDPR: Implications for the global Life Sciences industry
Live Webcast: Wednesday, December 13 at 2:00pm EDT
 Learn more
|
|
|
|
